FDH: An aldehyde dehydrogenase fusion enzyme in folate metabolism

Chemico-Biological Interactions

Volumn 178, Issue 1-3, 2009, Pages 84-93

  Krupenko, Sergey A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

10 Formyltetrahydrofolate dehydrogenase; 4 Phosphopantetheine; Aldehyde dehydrogenase; Enzyme mechanism; Folate metabolism; Functional domains

Indexed keywords

ALDEHYDE DEHYDROGENASE; CARRIER PROTEIN; CYSTEINE; FORMYLTETRAHYDROFOLATE DEHYDROGENASE; HYBRID PROTEIN; NICOTINAMIDE; PANTETHEINE PHOSPHATE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CATALYST; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FOLATE METABOLISM; IN VITRO STUDY; OXIDATION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY;

ALDEHYDE DEHYDROGENASE; BIOCATALYSIS; CATALYTIC DOMAIN; COENZYMES; CYSTEINE; FOLIC ACID; MODELS, MOLECULAR; NIACINAMIDE; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 59049107134     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.09.007     Document Type: Review

References (124)

1. Wagner C. Biochemical role of folate in cellular metabolism. In: Bailey L.B. (Ed). Folate in Health and Disease (1995), Marcel Dekker, Inc., New York 23-42
2. Benkovic S.J. The transformylase enzymes in de novo purine biosynthesis. Trends Biochem. Sci. 9 (1984) 320-322
3. Assaraf Y.G. Molecular basis of antifolate resistance. Cancer Metastasis Rev. 26 1 (2007) 153-181
4. Stanger O. Physiology of folic acid in health and disease. Curr. Drug Metab. 3 2 (2002) 211-223
5. Blom H.J., Shaw G.M., den Heijer M., and Finnell R.H. Neural tube defects and folate: case far from closed. Nat. Rev. Neurosci. 7 9 (2006) 724-731
6. Stover P.J. Physiology of folate and vitamin B12 in health and disease. Nutr. Rev. 62 6 Pt 2 (2004) S3-S12 discussion S13
7. Glynn S.A., and Albanes D. Folate and cancer: a review of the literature. Nutr. Cancer 22 (1994) 101-119
8. Jhaveri M.S., Wagner C., and Trepel J.B. Impact of extracellular folate levels on global gene expression. Mol. Pharmacol. 60 6 (2001) 1288-1295
9. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., Wickramasinghe S.N., Everson R.B., and Ames B.N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. U.S.A. 94 7 (1997) 3290-3295
10. Kruman I.I., Kumaravel T.S., Lohani A., Pedersen W.A., Cutler R.G., Kruman Y., Haughey N., Lee J., Evans M., and Mattson M.P. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 22 5 (2002) 1752-1762
11. Borman L.S., and Branda R.F. Nutritional folate deficiency in Chinese hamster ovary cells. I. Characterization of the pleiotropic response and its modulation by nucleic acid precursors. J. Cell. Physiol. 140 2 (1989) 335-343
12. Huang R.F., Ho Y.H., Lin H.L., Wei J.S., and Liu T.Z. Folate deficiency induces a cell cycle-specific apoptosis in HepG2 cells. J. Nutr. 129 1 (1999) 25-31
13. Chu E., and Allegra C.J. Antifolates. In: Chabner B.A., and Longo D.L. (Eds). Cancer Chemotherapy and Biotherapy: Principles and Practice (1996), Lippincott-Raven Publishers, Philadelphia 109-148
14. Cooper B.A. Folate nutrition in man and animals. In: Blakley R.L., and Whitehead V.M. (Eds). Folates and Pterins (1986), John Wiley & Sons, Inc., New York 49-74
15. Rock C.L., Lampe J.W., and Patterson R.E. Nutrition, genetics, and risks of cancer. Annu. Rev. Public Health 21 (2000) 47-64
16. Fleming A. The role of folate in the prevention of neural tube defects: human and animal studies. Nutr. Rev. 59 8 Pt 2 (2001) S13-20 discussion S21-13
17. Moat S.J., Lang D., McDowell I.F., Clarke Z.L., Madhavan A.K., Lewis M.J., and Goodfellow J. Folate, homocysteine, endothelial function and cardiovascular disease. J. Nutr. Biochem. 15 2 (2004) 64-79
18. Choi S.W., and Mason J.B. Folate and carcinogenesis: an integrated scheme. J. Nutr. 130 2 (2000) 129-132
19. Kisliuk R.L. Folate biochemistry in relation to antifolate selectivity. In: Jackman A.L. (Ed). Antifolate Drugs in Cancer Therapy (1999), Humana Press, Totowa, New Jersey 13-36
20. Horne D.W., Patterson D., and Cook R.J. Effect of nitrous oxide inactivation of vitamin B12-dependent methionine synthetase on the subcellular distribution of folate coenzymes in rat liver. Arch. Biochem. Biophys. 270 2 (1989) 729-733
21. Bianchetti R., Lucchini G., Crosti P., and Tortora P. Dependence of mitochondrial protein synthesis initiation on formylation of the initiator methionyl-tRNAf. J. Biol. Chem. 252 8 (1977) 2519-2523
22. Spencer A.C., and Spremulli L.L. Interaction of mitochondrial initiation factor 2 with mitochondrial fMet-tRNA. Nucleic Acids Res. 32 18 (2004) 5464-5470
23. Tibbetts A.S., Oesterlin L., Chan S.Y., Kramer G., Hardesty B., and Appling D.R. Mammalian mitochondrial initiation factor 2 supports yeast mitochondrial translation without formylated initiator tRNA. J. Biol. Chem. 278 34 (2003) 31774-31780
24. Beardsley G.P., Moroson B.A., Taylor E.C., and Moran R.G. A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis. J. Biol. Chem. 264 1 (1989) 328-333
25. Pizzorno G., Moroson B.A., Cashmore A.R., and Beardsley G.P. (6R)-5,10-Dideaza-5,6,7,8-tetrahydrofolic acid effects on nucleotide metabolism in CCRF-CEM human T-lymphoblast leukemia cells. Cancer Res. 51 9 (1991) 2291-2295
26. Pizzorno G., Davis S.J., Hartigan D.J., and Russello O. Enhancement of antineoplastic activity of 5-fluorouracil in mice bearing colon 38 tumor by (6R)5,10-dideazatetrahydrofolic acid. Biochem. Pharmacol. 47 11 (1994) 1981-1988
27. Mendelsohn L.G., Worzalla J.F., and Walling J.M. Preclinical and clinical evaluation of the glycinamide ribonucleotide formyltransferase inhibitors lometrexol and LY309887. In: Jackman A.L. (Ed). Antifolate Drugs in Cancer Therapy (1999), Humana Press, Totowa, New Jersey 261-280
28. MacKenzie R.E. Biogenesis and interconversion of substituted tetrahydrofolates. In: Blakley R.L., and Benkocic S.J. (Eds). Folates and Pterins (1984), John Wiley & Sons, Inc., New York 255-306
29. Hum D.W., Bell A.W., Rozen R., and MacKenzie R.E. Primary structure of a human trifunctional enzyme. Isolation of a cDNA encoding methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase. J. Biol. Chem. 263 31 (1988) 15946-15950
30. Krupenko S.A., and Oleinik N.V. 10-Formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells. Cell Growth Differ. 13 5 (2002) 227-236
31. Champion K.M., Cook R.J., Tollaksen S.L., and Giometti C.S. Identification of a heritable deficiency of the folate-dependent enzyme 10-formyltetrahydrofolate dehydrogenase in mice. Proc. Natl. Acad. Sci. U.S.A. 91 24 (1994) 11338-11342
32. Giometti C.S., Tollaksen S.L., and Grahn D. Altered protein expression detected in the F1 offspring of male mice exposed to fission neutrons. Mutat. Res. 320 1-2 (1994) 75-85
33. Oleinik N.V., Krupenko N.I., Priest D.G., and Krupenko S.A. Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression. Biochem. J. 391 Pt 3 (2005) 503-511
34. Tephly T.R. The toxicity of methanol. Life Sci. 48 11 (1991) 1031-1041
35. Anguera M.C., Field M.S., Perry C., Ghandour H., Chiang E.P., Selhub J., Shane B., and Stover P.J. Regulation of folate-mediated one-carbon metabolism by 10-formyltetrahydrofolate dehydrogenase. J. Biol. Chem. 281 27 (2006) 18335-18342
36. Epperson L.E., Dahl T.A., and Martin S.L. Quantitative analysis of liver protein expression during hibernation in the golden-mantled ground squirrel. Mol. Cell. Proteomics 3 9 (2004) 920-933
37. Leonard J.F., Courcol M., Mariet C., Charbonnier A., Boitier E., Duchesne M., Parker F., Genet B., Supatto F., Roberts R., and Gautier J.C. Proteomic characterization of the effects of clofibrate on protein expression in rat liver. Proteomics 6 6 (2006) 1915-1933
38. Osborn M.J., Hatefi Y., Kay L.D., and Huennekens F.M. Evidence for the enzymic deacylation of N10-formyl tetrahydro-folic acid. Biochim. Biophys. Acta 26 1 (1957) 208-210
39. Huennekens F.M., and Scrimgeour K.G. Methods Enzymol. 6 (1963) 673-675
40. Kutzbach C., and Stokstad E.L. Partial purification of a 10-formyl-tetrahydrofolate: NADP oxidoreductase from mammalian liver. Biochem. Biophys. Res. Commun. 30 2 (1968) 111-117
41. Kutzbach C., and Stokstad E.L.R. 10-Formyl tetrahydrofolate: NADP oxidoreductase. Methods Enzymol. 18B (1971) 793-798
42. Scrutton M.C., and Beis I. Inhibitory effects of histidine and their reversal. The roles of pyruvate carboxylase and N10-formyltetrahydrofolate dehydrogenase. Biochem. J. 177 3 (1979) 833-846
43. Min H., Shane B., and Stokstad E.L. Identification of 10-formyltetrahydrofolate dehydrogenase-hydrolase as a major folate binding protein in liver cytosol. Biochim. Biophys. Acta 967 3 (1988) 348-353
44. Rios-Orlandi E.M., Zarkadas C.G., and MacKenzie R.E. Formyltetrahydrofolate dehydrogenase-hydrolase from pig liver: simultaneous assay of the activities. Biochim. Biophys. Acta 871 1 (1986) 24-35
45. Case G.L., Kaisaki P.J., and Steele R.D. Resolution of rat liver 10-formyltetrahydrofolate dehydrogenase/hydrolase activities. J. Biol. Chem. 263 21 (1988) 10204-10207
46. Krupenko S.A., Wagner C., and Cook R.J. Recombinant 10-formyltetrahydrofolate dehydrogenase catalyses both dehydrogenase and hydrolase reactions utilizing the synthetic substrate 10-formyl-5,8-dideazafolate. Biochem. J. 306 Pt 3 (1995) 651-655
47. Cook R.J., Lloyd R.S., and Wagner C. Isolation and characterization of cDNA clones for rat liver 10-formyltetrahydrofolate dehydrogenase. J. Biol. Chem. 266 8 (1991) 4965-4973
48. Smith J.M., and Daum H.A. 3rd, Identification and nucleotide sequence of a gene encoding 5′-phosphoribosylglycinamide transformylase in Escherichia coli K12. J. Biol. Chem. 262 22 (1987) 10565-10569
49. Schild D., Brake A.J., Kiefer M.C., Young D., and Barr P.J. Cloning of three human multifunctional de novo purine biosynthetic genes by functional complementation of yeast mutations. Proc. Natl. Acad. Sci. U.S.A. 87 8 (1990) 2916-2920
50. Guillon J.M., Mechulam Y., Schmitter J.M., Blanquet S., and Fayat G. Disruption of the gene for Met-tRNA(fMet) formyltransferase severely impairs growth of Escherichia coli. J. Bacteriol. 174 13 (1992) 4294-4301
51. Hempel J., Nicholas H., and Lindahl R. Aldehyde dehydrogenases: widespread structural and functional diversity within a shared framework. Protein Sci. 2 11 (1993) 1890-1900
52. Perozich J., Nicholas H., Wang B.C., Lindahl R., and Hempel J. Relationships within the aldehyde dehydrogenase extended family. Protein Sci. 8 1 (1999) 137-146
53. Schirch D., Villar E., Maras B., Barra D., and Schirch V. Domain structure and function of 10-formyltetrahydrofolate dehydrogenase. J. Biol. Chem. 269 40 (1994) 24728-24735
54. Krupenko S.A., Wagner C., and Cook R.J. Domain structure of rat 10-formyltetrahydrofolate dehydrogenase. Resolution of the amino-terminal domain as 10-formyltetrahydrofolate hydrolase. J. Biol. Chem. 272 15 (1997) 10273-10278
55. Krupenko S.A., Wagner C., and Cook R.J. Expression, purification, and properties of the aldehyde dehydrogenase homologous carboxyl-terminal domain of rat 10-formyltetrahydrofolate dehydrogenase. J. Biol. Chem. 272 15 (1997) 10266-10272
56. Reuland S.N., Vlasov A.P., and Krupenko S.A. Modular organization of FDH: exploring the basis of hydrolase catalysis. Protein Sci. 15 5 (2006) 1076-1084
57. Chumanevich A.A., Krupenko S.A., and Davies C. The crystal structure of the hydrolase domain of 10-formyltetrahydrofolate dehydrogenase: mechanism of hydrolysis and its interplay with the dehydrogenase domain. J. Biol. Chem. 279 14 (2004) 14355-14364
58. Kursula P., Schuler H., Flodin S., Nilsson-Ehle P., Ogg D.J., Savitsky P., Nordlund P., and Stenmark P. Structures of the hydrolase domain of human 10-formyltetrahydrofolate dehydrogenase and its complex with a substrate analogue. Acta Crystallogr. D: Biol. Crystallogr. 62 Pt 11 (2006) 1294-1299
59. Rossmann M.G., Moras D., and Olsen K.W. Chemical and biological evolution of nucleotide-binding protein. Nature 250 463 (1974) 194-199
60. Murzin A.G. OB(oligonucleotide/oligosaccharide binding)-fold: common structural and functional solution for non-homologous sequences. EMBO J. 12 3 (1993) 861-867
61. Arcus V. OB-fold domains: a snapshot of the evolution of sequence, structure and function. Curr. Opin. Struct. Biol. 12 6 (2002) 794-801
62. Theobald D.L., Mitton-Fry R.M., and Wuttke D.S. Nucleic acid recognition by OB-fold proteins. Annu. Rev. Biophys. Biomol. Struct. 32 (2003) 115-133
63. Bochkarev A., and Bochkareva E. From RPA to BRCA2: lessons from single-stranded DNA binding by the OB-fold. Curr. Opin. Struct. Biol. 14 1 (2004) 36-42
64. Krupenko S.A., and Wagner C. Aspartate 142 is involved in both hydrolase and dehydrogenase catalytic centers of 10-formyltetrahydrofolate dehydrogenase. J. Biol. Chem. 274 50 (1999) 35777-35784
65. Almassy R.J., Janson C.A., Kan C.C., and Hostomska Z. Structures of apo and complexed Escherichia coli glycinamide ribonucleotide transformylase. Proc. Natl. Acad. Sci. U.S.A. 89 13 (1992) 6114-6118
66. Klein C., Chen P., Arevalo J.H., Stura E.A., Marolewski A., Warren M.S., Benkovic S.J., and Wilson I.A. Towards structure-based drug design: crystal structure of a multisubstrate adduct complex of glycinamide ribonucleotide transformylase at 1.96 A resolution. J. Mol. Biol. 249 1 (1995) 153-175
67. Krupenko S.A., Vlasov A.P., and Wagner C. On the role of conserved histidine 106 in 10-formyltetrahydrofolate dehydrogenase catalysis: connection between hydrolase and dehydrogenase mechanisms. J. Biol. Chem. 276 26 (2001) 24030-24037
68. Warren M.S., Marolewski A.E., and Benkovic S.J. A rapid screen of active site mutants in glycinamide ribonucleotide transformylase. Biochemistry 35 27 (1996) 8855-8862
69. Newton D.T., and Mangroo D. Mapping the active site of the Haemophilus influenzae methionyl-tRNA formyltransferase: residues important for catalysis and tRNA binding. Biochem. J. 339 Pt 1 (1999) 63-69
70. Schmitt E., Blanquet S., and Mechulam Y. Structure of crystalline Escherichia coli methionyl-tRNA(f)Met formyltransferase: comparison with glycinamide ribonucleotide formyltransferase. EMBO J. 15 17 (1996) 4749-4758
71. Schmitt E., Panvert M., Blanquet S., and Mechulam Y. Crystal structure of methionyl-tRNAfMet transformylase complexed with the initiator formyl-methionyl-tRNAfMet. EMBO J. 17 23 (1998) 6819-6826
72. Hentze M.W. Enzymes as RNA-binding proteins: a role for (di)nucleotide-binding domains?. Trends Biochem. Sci. 19 3 (1994) 101-103
73. Liu X., Reig B., Nasrallah I.M., and Stover P.J. Human cytoplasmic serine hydroxymethyltransferase is an mRNA binding protein. Biochemistry 39 38 (2000) 11523-11531
74. Weiner H., Farres J., Rout U.J., Wang X., and Zheng C.F. Site directed mutagenesis to probe for active site components of liver mitochondrial aldehyde dehydrogenase. Adv. Exp. Med. Biol. 372 (1995) 1-7
75. Farres J., Wang T.T., Cunningham S.J., and Weiner H. Investigation of the active site cysteine residue of rat liver mitochondrial aldehyde dehydrogenase by site-directed mutagenesis. Biochemistry 34 8 (1995) 2592-2598
76. Krupenko S.A., Wagner C., and Cook R.J. Cysteine 707 is involved in the dehydrogenase activity site of rat 10-formyltetrahydrofolate dehydrogenase. J. Biol. Chem. 270 2 (1995) 519-522
77. Liu Z.J., Sun Y.J., Rose J., Chung Y.J., Hsiao C.D., Chang W.R., Kuo I., Perozich J., Lindahl R., Hempel J., and Wang B.C. The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold. Nat. Struct. Biol. 4 4 (1997) 317-326
78. Steinmetz C.G., Xie P., Weiner H., and Hurley T.D. Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion. Structure 5 5 (1997) 701-711
79. Tsybovsky Y., Donato H., Krupenko N.I., Davies C., and Krupenko S.A. Crystal structures of the carboxyl terminal domain of rat 10-formyltetrahydrofolate dehydrogenase: implications for the catalytic mechanism of aldehyde dehydrogenases. Biochemistry 46 11 (2007) 2917-2929
80. Moore S.A., Baker H.M., Blythe T.J., Kitson K.E., Kitson T.M., and Baker E.N. Sheep liver cytosolic aldehyde dehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehyde dehydrogenases. Structure 6 12 (1998) 1541-1551
81. Johansson K., El-Ahmad M., Ramaswamy S., Hjelmqvist L., Jornvall H., and Eklund H. Structure of betaine aldehyde dehydrogenase at 2.1 A resolution. Protein Sci. 7 10 (1998) 2106-2117
82. Lamb A.L., and Newcomer M.E. The structure of retinal dehydrogenase type II at 2.7 A resolution: implications for retinal specificity. Biochemistry 38 19 (1999) 6003-6011
83. Habenicht A., Hellman U., and Cerff R. Non-phosphorylating GAPDH of higher plants is a member of the aldehyde dehydrogenase superfamily with no sequence homology to phosphorylating GAPDH. J. Mol. Biol. 237 1 (1994) 165-171
84. Cobessi D., Tete-Favier F., Marchal S., Azza S., Branlant G., and Aubry A. Apo and holo crystal structures of an NADP-dependent aldehyde dehydrogenase from Streptococcus mutans. J. Mol. Biol. 290 1 (1999) 161-173
85. Ahvazi B., Coulombe R., Delarge M., Vedadi M., Zhang L., Meighen E., and Vrielink A. Crystal structure of the NADP+-dependent aldehyde dehydrogenase from Vibrio harveyi: structural implications for cofactor specificity and affinity. Biochem. J. 349 Pt 3 (2000) 853-861
86. Perozich J., Kuo I., Lindahl R., and Hempel J. Coenzyme specificity in aldehyde dehydrogenase. Chem. Biol. Interact. 130-132 1-3 (2001) 115-124
87. Hurley T.D., Perez-Miller S., and Breen H. Order and disorder in mitochondrial aldehyde dehydrogenase. Chem. Biol. Interact. 130-132 1-3 (2001) 3-14
88. Perez-Miller S.J., and Hurley T.D. Coenzyme isomerization is integral to catalysis in aldehyde dehydrogenase. Biochemistry 42 23 (2003) 7100-7109
89. Gruez A., Roig-Zamboni V., Grisel S., Salomoni A., Valencia C., Campanacci V., Tegoni M., and Cambillau C. Crystal structure and kinetics identify Escherichia coli YdcW gene product as a medium-chain aldehyde dehydrogenase. J. Mol. Biol. 343 1 (2004) 29-41
90. Pohl E., Brunner N., Wilmanns M., and Hensel R. The crystal structure of the allosteric non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase from the hyperthermophilic archaeum Thermoproteus tenax. J. Biol. Chem. 277 22 (2002) 19938-19945
91. Hammen P.K., Allali-Hassani A., Hallenga K., Hurley T.D., and Weiner H. Multiple conformations of NAD and NADH when bound to human cytosolic and mitochondrial aldehyde dehydrogenase. Biochemistry 41 22 (2002) 7156-7168
92. Dittmer D.C., and Kolyer J.M. Addition of compounds of thiol and 1-substituted nicotinamides. J. Am. Chem. Soc. 28 (1963) 1720-1722
93. Metzler D.E. Biochemistry. The Chemical Reactions of Living Cells (1977), Academic Press, New York
94. Choe J., Guerra D., Michels P.A., and Hol W.G. Leishmania mexicana glycerol-3-phosphate dehydrogenase showed conformational changes upon binding a bi-substrate adduct. J. Mol. Biol. 329 2 (2003) 335-349
95. Benach J., Atrian S., Gonzalez-Duarte R., and Ladenstein R. The catalytic reaction and inhibition mechanism of Drosophila alcohol dehydrogenase: observation of an enzyme-bound NAD-ketone adduct at 1.4 A resolution by X-ray crystallography. J. Mol. Biol. 289 2 (1999) 335-355
96. Rubach J.K., and Plapp B.V. Amino acid residues in the nicotinamide binding site contribute to catalysis by horse liver alcohol dehydrogenase. Biochemistry 42 10 (2003) 2907-2915
97. Bossi R.T., Aliverti A., Raimondi D., Fischer F., Zanetti G., Ferrari D., Tahallah N., Maier C.S., Heck A.J., Rizzi M., and Mattevi A. A covalent modification of NADP+ revealed by the atomic resolution structure of FprA, a Mycobacterium tuberculosis oxidoreductase. Biochemistry 41 28 (2002) 8807-8818
98. Mohr S., Stamler J.S., and Brune B. Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment. J. Biol. Chem. 271 8 (1996) 4209-4214
99. Hempel J., Nicholas Jr. H.B., Brown S.T., and Wymore T. Unexpected encounters in simulations of the ALDH mechanism. In: Weiner H., Maser E., Lindahl R., and Plapp B. (Eds). Enzymology and Molecular Biology of Carbonyl Metabolism (2007), Purdue University Press 9-13
100. Wymore T., Deerfield II D.W., and Hempel J. Mechanistic implications of the cysteine-nicotinamide adduct in aldehyde dehydrogenase based on quantum mechanical/molecular mechanical simulations. Biochemistry 46 33 (2007) 9495-9506
101. Marchal S., and Branlant G. Evidence for the chemical activation of essential cys-302 upon cofactor binding to nonphosphorylating glyceraldehyde 3-phosphate dehydrogenase from Streptococcus mutans. Biochemistry 38 39 (1999) 12950-12958
102. Takahashi K., and Weiner H. Nicotinamide adenine dinucleotide activation of the esterase reaction of horse liver aldehyde dehydrogenase. Biochemistry 20 10 (1981) 2720-2726
103. Feldman R.I., and Weiner H. Horse liver aldehyde dehydrogenase. II. Kinetics and mechanistic implications of the dehydrogenase and esterase activity. J. Biol. Chem. 247 1 (1972) 267-272
104. Cook R.J., and Wagner C. Enzymatic activities of rat liver cytosol 10-formyltetrahydrofolate dehydrogenase. Arch. Biochem. Biophys. 321 2 (1995) 336-344
105. Weiner H., Hu J.H., and Sanny C.G. Rate-limiting steps for the esterase and dehydrogenase reaction catalyzed by horse liver aldehyde dehydrogenase. J. Biol. Chem. 251 13 (1976) 3853-3855
106. Zhou J., and Weiner H. Basis for half-of-the-site reactivity and the dominance of the K487 oriental subunit over the E487 subunit in heterotetrameric human liver mitochondrial aldehyde dehydrogenase. Biochemistry 39 39 (2000) 12019-12024
107. Weiner H., Wei B., and Zhou J. Subunit communication in tetrameric class 2 human liver aldehyde dehydrogenase as the basis for half-of-the-site reactivity and the dominance of the oriental subunit in a heterotetramer. Chem. Biol. Interact. 130-132 1-3 (2001) 47-56
108. Donato H., Krupenko N.I., Tsybovsky Y., and Krupenko S.A. 10-formyltetrahydrofolate dehydrogenase requires a 4′-phosphopantetheine prosthetic group for catalysis. J. Biol. Chem. 282 47 (2007) 34159-34166
109. Perham R.N. Swinging arms and swinging domains in multifunctional enzymes: catalytic machines for multistep reactions. Annu. Rev. Biochem. 69 (2000) 961-1004
110. Lai J.R., Koglin A., and Walsh C.T. Carrier protein structure and recognition in polyketide and nonribosomal peptide biosynthesis. Biochemistry 45 50 (2006) 14869-14879
111. White S.W., Zheng J., Zhang Y.M., and Rock. The structural biology of type II fatty acid biosynthesis. Annu. Rev. Biochem. 74 (2005) 791-831
112. Guo S., Evans S.A., Wilkes M.B., and Bhattacharjee J.K. Novel posttranslational activation of the LYS2-encoded alpha-aminoadipate reductase for biosynthesis of lysine and site-directed mutational analysis of conserved amino acid residues in the activation domain of Candida albicans. J. Bacteriol. 183 24 (2001) 7120-7125
113. Xu H., Andi B., Qian J., West A.H., and Cook P.F. The alpha-aminoadipate pathway for lysine biosynthesis in fungi. Cell Biochem. Biophys. 46 1 (2006) 43-64
114. Sacksteder K.A., Biery B.J., Morrell J.C., Goodman B.K., Geisbrecht B.V., Cox R.P., Gould S.J., and Geraghty M.T. Identification of the alpha-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia. Am. J. Hum. Genet. 66 6 (2000) 1736-1743
115. Reuland S.N., Vlasov A.P., and Krupenko S.A. Disruption of a calmodulin central helix-like region of 10-formyltetrahydrofolate dehydrogenase impairs its dehydrogenase activity by uncoupling the functional domains. J. Biol. Chem. 278 25 (2003) 22894-22900
116. Nagy P.L., Marolewski A., Benkovic S.J., and Zalkin H. Formyltetrahydrofolate hydrolase, a regulatory enzyme that functions to balance pools of tetrahydrofolate and one-carbon tetrahydrofolate adducts in Escherichia coli. J. Bacteriol. 177 5 (1995) 1292-1298
117. Nagy P.L., McCorkle G.M., and Zalkin H. purU, a source of formate for purT-dependent phosphoribosyl-N-formylglycinamide synthesis. J. Bacteriol. 175 21 (1993) 7066-7073
118. Tishkov V.I., and Popov V.O. Catalytic mechanism and application of formate dehydrogenase. Biochemistry (Mosc) 69 11 (2004) 1252-1267
119. Vogel C., Bashton M., Kerrison N.D., Chothia C., and Teichmann S.A. Structure, function and evolution of multidomain proteins. Curr. Opin. Struct. Biol. 14 2 (2004) 208-216
120. Bornberg-Bauer E., Beaussart F., Kummerfeld S.K., Teichmann S.A., and Weiner III J. The evolution of domain arrangements in proteins and interaction networks. Cell. Mol. Life Sci. 62 4 (2005) 435-445
121. Appling D.R., and Rabinowitz J.C. Regulation of expression of the ADE3 gene for yeast C1-tetrahydrofolate synthase, a trifunctional enzyme involved in one-carbon metabolism. J. Biol. Chem. 260 2 (1985) 1248-1256
122. Ivanetich K.M., and Santi D.V. Bifunctional thymidylate synthase-dihydrofolate reductase in protozoa. FASEB J. 4 6 (1990) 1591-1597
123. Davidson J.N., Chen K.C., Jamison R.S., Musmanno L.A., and Kern C.B. The evolutionary history of the first three enzymes in pyrimidine biosynthesis. Bioessays 15 3 (1993) 157-164
124. Martins A., and Shuman S. Characterization of a baculovirus enzyme with RNA ligase, polynucleotide 5′-kinase, and polynucleotide 3′-phosphatase activities. J. Biol. Chem. 279 18 (2004) 18220-18231